4 AUBANK share price target reports by brokerages below. See what is analyst's view on AUBANK share price forecast, rating, estimates, valuation and prediction behind the target. You may use these research report forecasts for long-term to medium term for your investment or trades in 2020.
AU Small Finance Bank (AUBANK) reported subdued earnings, impacted by higher provisions (INR1.4b) toward SMA accounts. Overdue loans stood at INR23b (8.5% of loans) as of April’20 v/s INR36b as of 1st Mar’20. 29% of customers (25% of the loan book) availed moratorium, which would be the key monitorable in the near term. On the business front, loan growth moderated, while deposits stood healthy. Margins were stable on a sequential basis despite excess liquidity buildup, with management suggesting spreads would improve further. We cut our earnings estimate for FY21/22 by 18%/10% as we factor in high credit cost and moderation in business growth. Maintain Buy.
AUBANK is swiftly increasing its focus toward high-yielding segments and capitalizing on under-penetrated opportunities in the MSME segment, thereby sustaining healthy growth momentum. The bank has been making adequate investments to support business growth (100 new branches and 2,736 employees added in the past one year), which will enable it to continually gain share in chosen business segments. We upgrade our FY21/FY22E PAT estimates by 12%/19% and revise our PT to INR1,100 (5.4x Sep’21E BV & 27x Sep-21E EPS). We have reiterated AUBANK as a top idea for CY20 in our banking outlook report and believe that given the surge in profitability rich valuations are here to stay. Maintain Buy.
Operating and financial leverage will continue to play through and nudge up RoAE to 23%-plus by FY21E. Leverage over 11x would likely drive a value-enhancing dilution by then, likely the first among many. The stock, trading at 5.5x FY20E P/BVPS, seems to be factoring this in. Maintain ‘BUY’ and our 12-month target price of INR880.
Our recent interaction with the top management of AUBANK, at their first analyst day, bolsters our constructive stance. Management’s intent to eventually convert into a full-fledged bank, via granular growth, was visible (AUBANK has to remain an SFB for at least ten more quarters). A book accretive fund raise is likely (though not immediately).Current asset quality trends are inspiring, amidst a bleak landscape. Increasing granularity will only help. Oplev (key to our anticipated RoAA expansion) has kicked in recently and is sustainable, in our view. Valuations are rich, but likely to persist so long as asset quality and growth hold up. Maintain BUY. Our SOTP-based TP is Rs 725 (4.75x Jun-21E ABV of Rs 148 + Rs 19/sh for AAVAS).
AUBANK is swiftly increasing its focus towards the high- yielding used vehicle segment and is capitalizing under-penetrated opportunities in the MSME segment, thereby sustaining healthy growth momentum. Further, the conservative underwriting approach, reduction in ticket sizes and lower LTVs should enable the bank to maintain strong control on credit costs. We expect AUBANK to deliver steady 43% earnings CAGR over FY19-21, aided by gradual improvement in operating leverage and margins. Maintain Buy with PT of INR760 (4.8x FY21E BV).
AUBANK has made strong progress on the business growth front, and alongside, has made adequate investments to support the growth momentum. We expect the bank to deliver steady progress in earnings/return ratios over FY19-21, aided by gradual improvement in operating leverage. We, thus, estimate ~43% earnings CAGR over FY19-21. Strong credit underwriting, diversified and a granular loan book coupled with a committed management should enable the stock to trade at premium valuations. We maintain Buy with PT of INR750 (4.7x FY21E BV).
Improved margins due to falling cost of funds (with increased share of deposits in external funds), along 21.9 with healthy loan book growth should act as a catalyst to spur the earnings growth of the company. The stock is currently trading at 3.6X P/ABV and 16.8X P/E of FY21E. We rate the stock a BUY, with a target price of INR 732, assigning a P/ABV of 4.2X of FY21E, with an upside of 18% from CMP.
AUBANKismakingstrongprogressinscalingupitsbusinessand alongside making adequate investments to support this momentum. We expect business growth to remain robust, while a gradual recovery in margins and cost- ratios will support earnings over the medium term. We revise up our PAT assumption by ~9%/6% for FY20/21, now estimating a PAT CAGR of 40% over FY19-21. Maintain Buy with an unchanged TP of INR720 (4.4x FY21E BV).
AUBANK’s scorching growth and near-flawless execution will keep valuations sustainably higher than peers. It holds the best of two worlds – NBFCs (high yielding, granular retail assets) and SFBs (rapidly expanding deposit franchise). Maintain BUY post the 4QFY19 beat. Our TP is Rs 680 (4.5x Mar-21E ABV of Rs 151). The bank’s demonstrable focus on growing both sides of the B/S continues to impress. With a large addressable opportunity, tepid competition from smaller NBFCs and sufficient capital, we expect growth to sustain. A reasonable fix on asset quality is an additional positive. Improvement in operating efficiency will be instrumental in driving RoAAs and is a key monitorable.
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.